# MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

> **NCT06000306** · — · COMPLETED · sponsor: **Zhejiang University** · enrollment: 192 (actual)

## Conditions studied

- Measurable Residual Disease

## Interventions

- **DIAGNOSTIC_TEST:** Digital Droplet PCR

## Key facts

- **NCT ID:** NCT06000306
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06000306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06000306, "MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06000306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*